Article

#4: Phacoemulsification Technology in Cataract Surgery

The first phacoemulsification cataract surgery, performed nearly 50 years ago by Charles Kelman, MD, in New York, was a 4-hour procedure that resulted in endophthalmitis and phthisis in a blind patient.

The first phacoemulsification cataract surgery, performed nearly 50 years ago by Charles Kelman, MD, in New York, was a 4-hour procedure that resulted in endophthalmitis and phthisis in a blind patient. Fortunately, Kelman, who is often remembered as the “father of phaco”, persisted with this new procedure, refining his technique and improving patient outcomes.

As with most new procedures, phacoemulsification took time to catch on among the surgical community. A 1984 survey showed that it was being used in less than 10% of all cataract surgeries, as extracapsular cataract extraction (ECCE) remained the dominant procedure due in part to the rigid nature of that era’s intraocular lenses (IOLs). At the time, experts predicted that there was little potential for growth in phaco procedures. In fact, even the most optimistic visionary expected phaco would be used in only 25% of all cataract surgeries.

How wrong those “visionaries” turned out to be. While new surgical techniques, including capsulorhexis, made the phaco procedure more reliable, it wasn’t until the introduction of the foldable IOL in 1989 that surgeons could take advantage of the smaller incisions made possible by phaco procedures. By 1990, phaco was being used in approximately 50% of all cataract surgeries. Five years later, ECCE had become nearly obsolete.

In the last 25 years, a number of key advances such as refinements in ultrasound systems, microsurgical incisions, and new hardware/software have given surgeons a variety of power options, better control of fluidics, and improved chamber stability. Kelman’s initial 4-hour procedure can now be completed in a matter of seconds.

Dense cataract image acquired with a Heidelberg Engineering swept-source OCT-based Cataract and Refractive Imaging Platform (in development, not available for sale).Prior to and following phaco procedures, optical coherence tomography is typically used to determine central macular thickness (CMT) at various time points, and to assess the link between CMT changes and surgical and biometric parameters.

How phacoemulsification procedures survive and evolve as the market for femtosecond laser continues to grow is a key question for the near future. Many surgeons today combine the use of a femtosecond laser and phaco (femtophaco) during cataract surgery, providing them with a piece of old technology to use with the new.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.